Read More

Why Core & Main Are Trading Lower By 7%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple oral drug candidates targeting inflammatory bowel disease.


Read More

Northern Dynasty’s Ability To Continue As A Going Concern Is Dependent On Its Ability To Finance Its Operating Costs, Complete Exploration And Development, Obtain Necessary Permits To Mine, And Achieve Future Profitable Production At The Pebble Project

- Form 6 Filing   Northern Dynasty prepared its Financial Statements on the basis that Northern Dynasty will continue as a going concern.  At March 31, 2023, the Company had working capital